Highlights

  • Singular Health signed a memorandum of understanding with Florida International University.
  • The project involves designing and operating a medical imaging data repository supporting Florida Medicaid.
  • The company estimates its potential project value at approximately A$3.5 million.
  • Definitive agreements and statements of work are still required before the project becomes binding.
  • The project is planned across three phases through to June 2027.

Singular Health Group Ltd (ASX:SHG) develops digital healthcare technology solutions, including medical imaging platforms. The company’s latest announcement outlines a memorandum of understanding with Florida International University for a medical imaging data repository project supporting Florida Medicaid and details the proposed structure, funding and development phases.

Florida Medicaid Imaging Repository Project

Singular Health announced that it has entered into a memorandum of understanding with Florida International University to design, deliver and operate a Medical Imaging Data Repository supporting Florida Medicaid.

The company stated that the project is expected to have a value of approximately A$3.5 million. However, the MOU remains non-binding except for obligations relating to entering into definitive agreements based on agreed minimum terms.

Funding Structure and Project Value

The project is supported by US$3.0 million of funding from the State of Florida for the 2026-27 financial year. Singular Health expects to receive approximately 85% of the funding allocation, with Florida International University receiving the remaining portion.

Payments are expected to be structured through milestones and tranches, with detailed arrangements to be finalised through definitive agreements. The company expects Revenue recognition during FY27 subject to completion of the required agreements and project delivery milestones.

Technology Platform and Project Scope

Singular Health plans to use its 3DICOM platform and MFTP transfer technology as part of the repository solution. The project is designed to allow previous medical imaging studies held by different providers to be located and shared.

The project is intended to address challenges associated with fragmented medical imaging records, including the potential duplication of scans across different healthcare providers.

Three-Phase Delivery Plan

The company outlined a three-phase delivery approach expected to continue through 30 June 2027. The first phase focuses on platform foundations and security architecture.

The second phase involves programme readiness and regulatory approvals, while the third phase includes a clinical and economic validation pilot designed to assess outcomes associated with the imaging repository.

Ownership and Commercial Considerations

Singular Health stated that it will retain ownership of its platform intellectual property. The agreement includes a five-year exclusivity provision relating specifically to Florida Medicaid projects.

The company retains the ability to pursue other commercial and non-Medicaid programmes in Florida and outside the state. The announcement does not provide cost estimates, margins or Capital requirements associated with delivery of the project.

Key Insights

Singular Health’s latest update outlines a healthcare technology collaboration focused on improving access to medical imaging data. The project provides details on the proposed platform application and delivery structure, while future outcomes depend on execution of definitive agreements, regulatory processes and milestone completion.